Literature DB >> 1365421

Dual actions of (-)-stepholidine on dopamine receptor subtypes after substantia nigra lesion.

G Z Jin1, K X Huang, B C Sun.   

Abstract

1. It was found that the contralateral rotation challenged by (-)-SPD (4 mg/kg, ip) in 6-OHDA-lesioned rats had a gradually progressive process with long latent period and a maximal response on 63 days after lesion. This steady contralateral rotation was preferably antagonized by D-1 antagonist SCH23390 than D-2 antagonists. During its latent period (-)-SPD exhibited the antagonistic effect to APO, while during its period of full response (-)-SPD could potentiate the APO-induced rotation. 2. In the rats lesioned with kainic acid plus 6-OHDA to destroy the SNC and SNR, (-)-SPD and SKF-38393 challenged neither contralateral nor ipsilateral rotation, while APO still induced the rotation but towards ipsilateral side, just opposite to that in 6-OHDA-lesioned rats. In this case, (-)-SPD antagonized the response to APO as did SCH 23390. 3. These evidences suggest that the agonistic action of (-)-SPD is resulted from D-1 receptor subtype at the SNR under supersensitive functional state. The fact that SNR lesion could completely eliminate the agonistic action of (-)-SPD further indicate that the D-1 receptors in the ipsilateral SNR may be the sites of action of (-)-SPD. The dual actions of (-)-SPD are dependent upon the supersensitivity of D-1 receptor subtypes which render the antagonistic action to convert into the agonistic.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365421     DOI: 10.1016/0197-0186(92)90234-i

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  4 in total

1.  (-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling.

Authors:  Julie A Meade; R Benjamin Free; Nicole R Miller; Lani S Chun; Trevor B Doyle; Amy E Moritz; Jennie L Conroy; Val J Watts; David R Sibley
Journal:  Psychopharmacology (Berl)       Date:  2014-09-18       Impact factor: 4.530

Review 2.  Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction.

Authors:  Hongyuan Chu; Guozhang Jin; Eitan Friedman; Xuechu Zhen
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

3.  The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist.

Authors:  Sridhar Natesan; Greg E Reckless; Karen B L Barlow; John Odontiadis; José N Nobrega; Glen B Baker; Susan R George; David Mamo; Shitij Kapur
Journal:  Psychopharmacology (Berl)       Date:  2008-06-03       Impact factor: 4.530

4.  The neuropharmacology of (-)-stepholidine and its potential applications.

Authors:  Kechun Yang; Guozhang Jin; Jie Wu
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.